BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 28910601)

  • 1. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
    Li Z; Zhang C; Fan J; Yuan C; Huang J; Chen J; Yi Z; Wang Z; Hong W; Wang Y; Lu W; Guan Y; Wu Z; Su Y; Cao L; Hu Y; Hao Y; Liu M; Yu S; Cui D; Xu L; Song Y; Fang Y
    Br J Psychiatry; 2014 Jul; 205(1):29-35. PubMed ID: 24764546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum protein profiles between major depressive disorder and bipolar disorder.
    Rhee SJ; Han D; Lee Y; Kim H; Lee J; Lee K; Shin H; Kim H; Lee TY; Kim M; Kim SH; Ahn YM; Kwon JS; Ha K
    BMC Psychiatry; 2020 Apr; 20(1):145. PubMed ID: 32245436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
    Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
    Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression.
    Zhao G; Zhang C; Chen J; Su Y; Zhou R; Wang F; Xia W; Huang J; Wang Z; Hu Y; Cao L; Guo X; Yuan C; Wang Y; Yi Z; Lu W; Wu Y; Wu Z; Hong W; Peng D; Fang Y
    Mol Neurobiol; 2017 Sep; 54(7):5573-5582. PubMed ID: 27613282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
    Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry.
    Kim H; Rhee SJ; Lee H; Han D; Lee TY; Kim M; Kim EY; Kwon JS; Shin H; Kim H; Ahn YM; Ha K
    Psychiatry Res; 2021 May; 299():113850. PubMed ID: 33711561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
    Hashimoto K
    Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the phenomenology of depressive episodes in bipolar I and II disorder and major depressive disorder within bipolar disorder pedigrees.
    Frankland A; Cerrillo E; Hadzi-Pavlovic D; Roberts G; Wright A; Loo CK; Breakspear M; Mitchell PB
    J Clin Psychiatry; 2015 Jan; 76(1):32-8; quiz 39. PubMed ID: 25650671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients.
    Santa Cruz EC; Zandonadi FDS; Fontes W; Sussulini A
    Biochim Biophys Acta Proteins Proteom; 2021 Aug; 1869(8):140657. PubMed ID: 33839315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of plasma biomarkers for diffuse axonal injury in rats by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Zhang P; Zhu S; Zhao M; Zhao P; Zhao H; Deng J; Li J
    Brain Res Bull; 2018 Sep; 142():224-232. PubMed ID: 30077728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
    Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
    J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of Differential Expression Proteins in Rat Brain Tissues after DAI by iTRAQ-LC-MS/MS].
    Chen Q; Bai J; Zhang WF
    Fa Yi Xue Za Zhi; 2017 Aug; 33(4):348-352. PubMed ID: 29219262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.